MedTrace Logo

Vitamin D Supplementation in CKD - Vascular Function, Structure and Immune Regulation

NCT04380467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-05-08

No results posted yet for this study

Summary

A pilot study to assess feasibility of methods of an observer-blinded randomised controlled trial of the effect of vitamin D supplementation in Chronic Kidney Disease and low vitamin D levels on markers of vascular function (Flow Mediated Dilatation of Brachial Artery), vascular structure (Carotid Intima Media Thickness) and Immune Regulation (frequencies of CD4+CD28null T lymphocytes ad Regulatory T lymphocytes).

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D (cholecalciferol)

(aviticol) 5x 20,000unit capsules administered monthly over 20 weeks

Sponsors & Collaborators

  • St George's, University of London

    lead OTHER

Principal Investigators

  • Debasish Banarjee · St Georges University NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04380467 on ClinicalTrials.gov